Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-29

FDA Approved: NORELGESTROMIN AND ETHINLY ESTRADIOL — Supplemental Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

The FDA approved a supplemental application for the generic combined oral contraceptive product NORELGESTROMIN AND ETHINLY ESTRADIOL from Amneal Pharmaceuticals…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NORELGESTROMIN AND ETHINLY ESTRADIOL (NORELGESTROMIN AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for NORELGESTROMIN AND ETHINLY ESTRADIOL (NORELGESTROMIN AND ETHINLY ESTRADIOL)